MANE:NYSEVeradermics, Incorporated analysis
Data as of Oct 10, 2026 - not real-time
- Latest price
- $130.90
- Risk: medium
- 7/10Medium risk
Summary
Veradermics, Incorporated is priced at $130.90 and its moving averages line up in bullish order, the shorter sitting above the longer. It has gained 28.6% over the past 30 days. Relative strength is 67.0 — approaching overbought — and the MACD signal is bullish. Recent trading has carved out support near $98.46 and resistance around $136.72.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 24.9% above where the shares trade now.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 62.4%, a beta of 0.84 and a maximum drawdown of 24.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 2/10 conviction on the long call.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 24.9% above where the shares trade now.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 62.4%, a beta of 0.84 and a maximum drawdown of 24.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 2/10 conviction on the long call.
Top market events
- Bloomberg reported on August 29 that hair-loss drug stocks are surging as Wall Street bets on a new pharmaceutical...
- Veradermics Incorporated stocks have been trading up by 14.
- Veradermics Incorporated stocks have been trading up by 11.
Market outlook
Short term
< 1 yearPositive
Model confidence5/105 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 90.72
- MACD momentum is positive
Medium term
1–3 yearsNeutral
Model confidence3/103 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 90.72
- Analyst targets imply +24.9% versus the current price
Long term
> 3 yearsNeutral
Model confidence2/102 out of 10
Key factors
- Analyst targets imply +24.9% versus the current price
- 30-day volatility of 62.4%
- Price-to-book of 6.72
Key metrics
Financial health
P/E Ratio-48.7
Debt/Equity0.05
P/B Ratio6.7
Op. Cash Flow$-78300000
Industry P/E30.5
Technical analysis
TrendBullish
RSI67.0
Support$98.46
Resistance$136.72
MA 20$114.34
MA 50$108.43
MA 200$90.72
MACDBullish
VolumeStable
Fear & Greed Index94.93
Valuation
Target Price$163.50
Upside/Downside24.90%
GradeFair
TypeGrowth
Risk assessment
Beta0.84
Volatility62.45%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.